文献速递牙体牙髓病

重新定义牙髓病理演变:炎症小体作为中枢整合枢纽与生物开关,调控可复性向不可复性牙髓炎的转变

Redefining the Evolution of Pulpal Pathology: Inflammasomes as Central Integrative Hubs and Biological Switches Governing the Transition From Reversible to Irreversible Pulpal Inflammation Beyond Symptom-Based Classification.
PubMed 文献 · Int Endod J · 2026-05-26

本文通过结构化叙述性综述整合体外、动物及人牙髓组织证据,提出炎症小体是牙髓炎症的分子决策平台。炎症小体启动后可逆,但ASC斑点形成标志不可逆转折点,导致caspase-1激活、gasdermin D介导的焦亡及IL-1β/IL-18成熟,驱动自我维持的炎症循环。该模型超越症状分类,可能 redefine 活髓治疗的生物学界限。

要点

  • 牙髓细胞表达NLRP3、AIM2、NLRP6等功能性炎症小体传感器。
  • ASC斑点形成是不可逆牙髓炎的分子承诺点,导致焦亡和细胞因子释放。
  • 线粒体功能障碍、mtDNA释放、P2X7信号等放大炎症小体活性,形成正反馈。

核心结论

  • 牙髓炎症应理解为炎症小体检查点失败驱动的生物转变,而非微生物负荷线性增加。
  • 不可逆的ASC斑点形成作为承诺开关,维持caspase-1激活、gasdermin D介导焦亡及自我放大的IL-1β/IL-18信号。
  • 在封闭的牙髓环境中,前馈炎症电路导致神经血管失调和剧痛,最终与初始损伤解耦且组织无法恢复。
  • 识别炎症小体激活(ASC斑点形成)为不可逆点可能改进诊断范式并重新定义活髓治疗的生物学界限。

研究设计与样本

  • 综合体外系统、体内动物模型及人炎症牙髓组织分析的证据。

主要发现

  • 牙髓细胞表达功能性炎症小体传感器,包括NLRP3、AIM2和NLRP6,响应炎症、代谢和损伤相关信号。
  • 炎症小体激活遵循转录启动和阈值依赖组装的逐步过程。
  • NF-κB和I型干扰素介导的启动是适应性的且可能可逆,而ASC斑点形成代表分子承诺点。
  • ASC斑点形成导致caspase-1激活、gasdermin D裂解、IL-1β/IL-18成熟和焦亡性细胞死亡。
  • 线粒体功能障碍、胞质mtDNA释放、持续离子流、P2X7信号和内源性抑制调节因子丧失放大炎症小体活性,促进自我维持炎症电路和进行性组织破坏。

关键数值与推荐

  • 炎症小体激活的阈值依赖组装区分可逆与不可逆牙髓炎症。
  • ASC斑点形成作为不可逆牙髓炎的分子承诺点。
  • NF-κB和I型干扰素介导的启动具有适应性且潜在可逆。

临床怎么用

  • 将炎症小体激活(ASC斑点形成)视为不可逆点,可能改进诊断范式。
  • 重新定义活髓治疗的生物学界限,超越症状分类。

局限性

  • 本文为叙述性综述,未报告系统评价方法学质量评估。
  • 证据来自体外、动物及人组织分析的综合,缺乏统一量化标准。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The transition from reversible to irreversible pulpitis remains inadequately defined at the molecular level. Current classifications rely largely on clinical symptoms rather than objective biological determinants, limiting diagnostic precision and therapeutic decision-making. OBJECTIVES: To integrate current experimental and translational evidence positioning inflammasomes as central molecular decision-making platforms in pulpal inflammation, and to propose a biologically grounded model in which inflammasome activation and supramolecular assembly define the threshold separating adaptive, reversible inflammation from irreversible pulpal damage, with direct clinical implications. METHODS: A structured narrative review was conducted following a comprehensive literature search of PubMed/MEDLINE, Scopus, and Web of Science from inception to December 2025. Evidence derived from in vitro systems, in vivo animal models, and analyses of human inflamed pulpal tissues was synthesised to characterise inflammasome sensors, adaptor and effector components, regulatory checkpoints, downstream inflammatory outputs, and their relevance to pulpal disease progression. RESULTS: Dental pulp cells express functional inflammasome sensors, including NLRP3, AIM2, and NLRP6, which respond to inflammatory, metabolic, and damage-associated signals. Inflammasome activation follows a stepwise process of transcriptional priming and threshold-dependent assembly. While NF-κB- and type I interferon-mediated priming is adaptive and potentially reversible, ASC speck formation represents a molecular commitment point leading to caspase-1 activation, gasdermin D cleavage, IL-1β/IL-18 maturation, and pyroptotic cell death. Mitochondrial dysfunction, cytosolic mtDNA release, sustained ion fluxes, P2X7 signalling, and loss of endogenous inhibitory regulators further amplify inflammasome activity, promoting self-sustaining inflammatory circuits and progressive tissue breakdown. CONCLUSIONS: Pulpal inflammation should be understood not as a linear increase in microbial burden, but as a biological transition driven by inflammasome checkpoint failure. Irreversible ASC speck formation functions as a commitment switch that sustains caspase-1 activation, gasdermin D-mediated pyroptosis, and self-amplifying IL-1β/IL-18 signalling. Within the confined pulp environment, this feed-forward inflammatory circuitry promotes neurovascular dysregulation and severe pain, ultimately becoming uncoupled from the initiating insult and incompatible with tissue recovery. Recognising Inflammasome activation (ASC speck formation) as a point of no return may refine diagnostic paradigms and help redefine the biological limits of vital pulp therapy.

来源:Int Endod J,查看原文。版权归原作者所有。

引用

  1. Ríos-Osorio N, Gutmann JL, Botero TM, et al. Redefining the Evolution of Pulpal Pathology: Inflammasomes as Central Integrative Hubs and Biological Switches Governing the Transition From Reversible to Irreversible Pulpal Inflammation Beyond Symptom-Based Classification. Int Endod J. 2026. PMID: 42186678. doi:10.1111/iej.70185

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。